pubmed-article:17318853 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17318853 | lifeskim:mentions | umls-concept:C0040732 | lld:lifeskim |
pubmed-article:17318853 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:17318853 | lifeskim:mentions | umls-concept:C0206754 | lld:lifeskim |
pubmed-article:17318853 | lifeskim:mentions | umls-concept:C0023884 | lld:lifeskim |
pubmed-article:17318853 | lifeskim:mentions | umls-concept:C1522484 | lld:lifeskim |
pubmed-article:17318853 | lifeskim:mentions | umls-concept:C0036525 | lld:lifeskim |
pubmed-article:17318853 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:17318853 | pubmed:dateCreated | 2007-3-5 | lld:pubmed |
pubmed-article:17318853 | pubmed:abstractText | Liver transplantation can be a therapeutic option for individual patients with neuroendocrine tumors metastatic only to the liver. In this consecutive series of 15 patients (5 multivisceral and 10 orthotopic liver transplantations) with well-differentiated carcinoids, or endocrine pancreatic tumors, we allowed higher proliferation rate (Ki67 <10%), large tumor burden, and higher age than previous studies. Liver transplantation offered good relief of symptoms, long disease-free intervals, and potential cure in individual patients. The survival of grafts and patients compared well with transplantation for benign disease. The overall 5-year survival was 90%. The recurrence-free survival of both multivisceral and liver transplantation related to the time after transplantation (about 20% at 5 years) despite inclusion of patients with higher risk. In conclusion, the critical prognosticators for long-term outcome still remain to be defined. The experience with multivisceral transplantation for patients with endocrine tumors of the pancreatic head is still limited. | lld:pubmed |
pubmed-article:17318853 | pubmed:language | eng | lld:pubmed |
pubmed-article:17318853 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17318853 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:17318853 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17318853 | pubmed:month | Mar | lld:pubmed |
pubmed-article:17318853 | pubmed:issn | 1527-6465 | lld:pubmed |
pubmed-article:17318853 | pubmed:author | pubmed-author:AhlmanHåkanH | lld:pubmed |
pubmed-article:17318853 | pubmed:author | pubmed-author:WängbergBoB | lld:pubmed |
pubmed-article:17318853 | pubmed:author | pubmed-author:NilssonOlaO | lld:pubmed |
pubmed-article:17318853 | pubmed:author | pubmed-author:FrimanStyrbjö... | lld:pubmed |
pubmed-article:17318853 | pubmed:author | pubmed-author:JanssonSvante... | lld:pubmed |
pubmed-article:17318853 | pubmed:author | pubmed-author:OlaussonMicha... | lld:pubmed |
pubmed-article:17318853 | pubmed:author | pubmed-author:CahlinChristi... | lld:pubmed |
pubmed-article:17318853 | pubmed:author | pubmed-author:HerleniusGust... | lld:pubmed |
pubmed-article:17318853 | pubmed:copyrightInfo | (c) 2007 AASLD. | lld:pubmed |
pubmed-article:17318853 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:17318853 | pubmed:volume | 13 | lld:pubmed |
pubmed-article:17318853 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17318853 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17318853 | pubmed:pagination | 327-33 | lld:pubmed |
pubmed-article:17318853 | pubmed:meshHeading | pubmed-meshheading:17318853... | lld:pubmed |
pubmed-article:17318853 | pubmed:meshHeading | pubmed-meshheading:17318853... | lld:pubmed |
pubmed-article:17318853 | pubmed:meshHeading | pubmed-meshheading:17318853... | lld:pubmed |
pubmed-article:17318853 | pubmed:meshHeading | pubmed-meshheading:17318853... | lld:pubmed |
pubmed-article:17318853 | pubmed:meshHeading | pubmed-meshheading:17318853... | lld:pubmed |
pubmed-article:17318853 | pubmed:meshHeading | pubmed-meshheading:17318853... | lld:pubmed |
pubmed-article:17318853 | pubmed:meshHeading | pubmed-meshheading:17318853... | lld:pubmed |
pubmed-article:17318853 | pubmed:meshHeading | pubmed-meshheading:17318853... | lld:pubmed |
pubmed-article:17318853 | pubmed:meshHeading | pubmed-meshheading:17318853... | lld:pubmed |
pubmed-article:17318853 | pubmed:meshHeading | pubmed-meshheading:17318853... | lld:pubmed |
pubmed-article:17318853 | pubmed:meshHeading | pubmed-meshheading:17318853... | lld:pubmed |
pubmed-article:17318853 | pubmed:meshHeading | pubmed-meshheading:17318853... | lld:pubmed |
pubmed-article:17318853 | pubmed:meshHeading | pubmed-meshheading:17318853... | lld:pubmed |
pubmed-article:17318853 | pubmed:meshHeading | pubmed-meshheading:17318853... | lld:pubmed |
pubmed-article:17318853 | pubmed:meshHeading | pubmed-meshheading:17318853... | lld:pubmed |
pubmed-article:17318853 | pubmed:meshHeading | pubmed-meshheading:17318853... | lld:pubmed |
pubmed-article:17318853 | pubmed:meshHeading | pubmed-meshheading:17318853... | lld:pubmed |
pubmed-article:17318853 | pubmed:meshHeading | pubmed-meshheading:17318853... | lld:pubmed |
pubmed-article:17318853 | pubmed:meshHeading | pubmed-meshheading:17318853... | lld:pubmed |
pubmed-article:17318853 | pubmed:year | 2007 | lld:pubmed |
pubmed-article:17318853 | pubmed:articleTitle | Orthotopic liver or multivisceral transplantation as treatment of metastatic neuroendocrine tumors. | lld:pubmed |
pubmed-article:17318853 | pubmed:affiliation | Sahlgrenska Transplant Institute, Sahlgrenska Academy, University of Göteborg, Göteborg, Sweden. | lld:pubmed |
pubmed-article:17318853 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:17318853 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17318853 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17318853 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17318853 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17318853 | lld:pubmed |